Studies have also shown downregulation of PTHR1 mRNA in osteoblasts in ESRD patients [34] while another study found higher PTHR1 in bone compared to healthy controls in earlier CKD stages (stages 2–3) while stage 5 CKD, when circulating intact PTH was highest, was not different from control levels [35]. This evidence concerns the gene PTH and chronic kidney disease.